A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144
C4551007
Phase 1 other active
Quick answer
A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144 for locally advanced or metastatic ER+/HER2- breast cancer is a Phase 1 program (other) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- locally advanced or metastatic ER+/HER2- breast cancer
- Phase
- Phase 1
- Modality
- other
- Status
- active